NEOVASCULARIZATION IS ASSOCIATED WITH A SWITCH TO THE EXPORT OF BFGF IN THE MULTISTEP DEVELOPMENT OF FIBROSARCOMA

被引:494
作者
KANDEL, J
BOSSYWETZEL, E
RADVANYI, F
KLAGSBRUN, M
FOLKMAN, J
HANAHAN, D
机构
[1] HARVARD UNIV, SCH MED, DEPT SURG, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT BIOL CHEM, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT ANAT & CELLULAR BIOL, BOSTON, MA 02115 USA
[4] UNIV CALIF SAN FRANCISCO, HORMONE RES INST, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA
关键词
D O I
10.1016/0092-8674(91)90033-U
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a transgenic mouse model, dermal fibrosarcomas develop in a pathway comprised of at least three stages: mild fibromatosis, aggressive fibromatosis, and fibrosarcoma. The latter two stages are highly vascularized when compared with both the normal dermis and the initial mild lesion. Analysis of cell cultures derived from biopsies of these lesions has revealed that basic fibroblast growth factor (bFGF) is synthesized in all three stages and in normal dermal fibroblasts derived from the same mice. Unexpectedly, there is a change in the localization of bFGF from its normal cell-associated state to extracellular release in the latter two stages, which is concomitant both with the neovascularization seen in vivo and with the tumorigenicity of these cell lines. Thus, in this multistep tumorigenesis pathway there appears to be a discrete switch to the angiogenic phenotype that correlates with the export of bFGF, a known angiogenic factor.
引用
收藏
页码:1095 / 1104
页数:10
相关论文
共 48 条
[1]   IMMUNOREACTIVE FIBROBLAST GROWTH-FACTOR (FGF) IN A TRANSPLANTABLE CHONDROSARCOMA - INHIBITION OF TUMOR-GROWTH BY ANTIBODIES TO FGF [J].
BAIRD, A ;
MORMEDE, P ;
BOHLEN, P .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, 30 (01) :79-85
[2]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[3]   AN ONCOGENE ISOLATED BY TRANSFECTION OF KAPOSIS-SARCOMA DNA ENCODES A GROWTH-FACTOR THAT IS A MEMBER OF THE FGF FAMILY [J].
BOVI, PD ;
CURATOLA, AM ;
KERN, FG ;
GRECO, A ;
ITTMANN, M ;
BASILICO, C .
CELL, 1987, 50 (05) :729-737
[4]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[5]   EVIDENCE FOR EXPORT OF A MUSCLE LECTIN FROM CYTOSOL TO EXTRACELLULAR-MATRIX AND FOR A NOVEL SECRETORY MECHANISM [J].
COOPER, DNW ;
BARONDES, SH .
JOURNAL OF CELL BIOLOGY, 1990, 110 (05) :1681-1691
[6]  
DELAPEYRIERE O, 1990, ONCOGENE, V5, P823
[7]   POTENTIAL ONCOGENE PRODUCT RELATED TO GROWTH-FACTORS [J].
DICKSON, C ;
PETERS, G .
NATURE, 1987, 326 (6116) :833-833
[8]   THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE [J].
ENDICOTT, JA ;
LING, V .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :137-171
[9]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858
[10]   HUMAN KGF IS FGF-RELATED WITH PROPERTIES OF A PARACRINE EFFECTOR OF EPITHELIAL-CELL GROWTH [J].
FINCH, PW ;
RUBIN, JS ;
MIKI, T ;
RON, D ;
AARONSON, SA .
SCIENCE, 1989, 245 (4919) :752-755